Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Total Current Liabilities (2016 - 2025)

Ptc Therapeutics has reported Total Current Liabilities over the past 14 years, most recently at $968.4 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $968.4 million for Q4 2025, up 66.69% from a year ago — trailing twelve months through Dec 2025 was $968.4 million (up 66.69% YoY), and the annual figure for FY2025 was $968.4 million, up 66.69%.
  • Total Current Liabilities for Q4 2025 was $968.4 million at Ptc Therapeutics, up from $866.2 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for PTCT hit a ceiling of $968.4 million in Q4 2025 and a floor of $250.9 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $538.4 million (2021), compared with a mean of $541.7 million.
  • Peak annual rise in Total Current Liabilities hit 95.0% in 2022, while the deepest fall reached 20.24% in 2022.
  • Ptc Therapeutics' Total Current Liabilities stood at $509.3 million in 2021, then decreased by 20.24% to $406.2 million in 2022, then soared by 48.46% to $603.1 million in 2023, then dropped by 3.67% to $581.0 million in 2024, then surged by 66.69% to $968.4 million in 2025.
  • The last three reported values for Total Current Liabilities were $968.4 million (Q4 2025), $866.2 million (Q3 2025), and $627.8 million (Q2 2025) per Business Quant data.